Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
It is our pleasure to invite you to the First Annual NAFLD & NASH Primary Care Summit. This important multidisciplinary program will be held online December 1, 2022 from 5:30pm – 10:00pm EST.
Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are becoming a major cause of liver disease worldwide. NAFLD is estimated to have a prevalence of 25-40% in Canada, and NASH, 3-4%. NAFLD is the most common chronic liver disease in Canada, the second leading cause of liver transplantation, and will soon be the leading cause within 10 years. NASH is also the fastest-rising cause of hepatocellular carcinoma (HCC), the second leading cause of cancer-related death in the world.
On behalf of our co-chairs and esteemed faculty, we hope you will join us virtually for this important meeting that will pave the future of practice of NAFLD and NASH across Canada and beyond.
Michael Betel, our President and Founder presented at the Canadian Liver Meeting 2022. What drove the creation of FLA?